TABLE 1.

Antifungal susceptibility results for clinical isolates of Lichtheimia spp.

DrugaTime (h) assessedMIC forb:
All Lichtheimia isolates (44)L. ramosa (24)L. corymbifera (19)L. ornata (1)
GMRangeGMRangeGMRange
AMB240.070.015-0.50.080.015-0.50.070.015-0.250.12
480.140.015-0.50.140.015-0.50.140.06-0.250.12
ITC240.770.06-160.920.25-80.620.06-160.5
481.650.12-162.380.25-161.030.125-161
VCZ2411.890.5-1612.574-1611.110.5-1616
4813.342-1615.068-1611.522-1616
vRVC241.390.06-161.440.5-41.340.06-161
482.570.12-163.421-81.860.125-162
PSC240.340.12-160.320.125-0.50.370.125-160.25
480.630.12-160.690.25-20.580.125-160.25
TRB240.520.03-320.560.03-40.480.06-320.25
480.880.06-3210.06-40.750.25-320.5
CAS2410.140.015-3211.040.03-329.270.015-3232
4814.780.015-3221.380.015-3210.010.015-3232
MIC247.790.015-326.850.015-328.920.015-3232
4816.560.015-3221.380.015-3212.640.03-3232
AND242.740.015-323.580.03-321.990.015-324
487.230.015-325.150.015-3210.810.06-3232
  • a AMB, amphotericin B; ITC, itraconazole; VCZ, voriconazole; RVZ, ravuconazole; PSC, posaconazole; TRB, terbinafine; CAS, caspofungin; MIC, micafungin; AND, anidulafungin.

  • b The number of isolates is shown in parentheses.